<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02589171</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-15-0668</org_study_id>
    <nct_id>NCT02589171</nct_id>
  </id_info>
  <brief_title>The neoClose Abdominal Closure vs Carter-Thomason Trial</brief_title>
  <official_title>Randomized Trial Evaluating Effectiveness of neoClose Abdominal Closure Device Versus Carter-Thomason Needle Passer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NeoSurgical Limited</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the neoClose abdominal closure to the standard
      Carter-Thomason closure in a bariatric surgery gastric bypass population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Both the neoClose abdominal closure to the standard Carter-Thomason closure will be used to
      close 12 mm camera port sites and 12 mm stapler port sites upon completion of a robotic
      assisted laparoscopic gastric bypass. The procedure requires a 12 mm port site be placed in
      the midline approximately 3 cm cephalad to the umbilicus and a second 12mm port site in the
      right mid abdomen. Port sites will be closed as defined as the inability to palpate a fascial
      defect and the incision being air tight upon carbon dioxide insufflation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 12, 2016</start_date>
  <completion_date type="Actual">April 25, 2018</completion_date>
  <primary_completion_date type="Actual">April 25, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Technical Effectiveness as Assessed by Number of Sutures Required to Complete Closure at the Camera Port Site</measure>
    <time_frame>at the time of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Technical Effectiveness as Assessed by Number of Sutures Required to Complete Closure at the Stapler Port Site</measure>
    <time_frame>at the time of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Technical Effectiveness as Assessed by the Time Required to Complete Closure at the Camera Port Site</measure>
    <time_frame>at the time of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Technical Effectiveness as Assessed by the Time Required to Complete Closure at the Stapler Port Site</measure>
    <time_frame>at the time of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Technical Effectiveness as Assessed by Depth of Needle Penetration to Complete Closure at Both the Camera Port Site and Stapler Port Site</measure>
    <time_frame>at the time of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Technical Effectiveness as Assessed by Number of Participants With Surgical Site Occurrences Post-Operatively</measure>
    <time_frame>immediately post op</time_frame>
    <description>Surgical site occurrences include hematoma, seroma, or infection and were assessed by physical exam.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Technical Effectiveness as Assessed by Number of Participants With Surgical Site Occurrences Post-Operatively</measure>
    <time_frame>1 week</time_frame>
    <description>Surgical site occurrences include hematoma, seroma, or infection and were assessed by physical exam.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Technical Effectiveness as Assessed by Number of Participants With Surgical Site Occurrences Post-Operatively</measure>
    <time_frame>6 weeks</time_frame>
    <description>Surgical site occurrences include hematoma, seroma, or infection and were assessed by physical exam.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Technical Effectiveness as Assessed by Number of Participants With Presence of Port Site Hernia Post-operatively</measure>
    <time_frame>6 weeks</time_frame>
    <description>Abdominal ultrasound will be used to detect port site hernia.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at the 12mm Camera Port Site as Assessed by a Visual Analog Scale</measure>
    <time_frame>day 1</time_frame>
    <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at the 12mm Camera Port Site as Assessed by a Visual Analog Scale</measure>
    <time_frame>1 week</time_frame>
    <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at the 12mm Camera Port Site as Assessed by a Visual Analog Scale</measure>
    <time_frame>6 weeks</time_frame>
    <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at the Stapler Port Site as Assessed by a Visual Analog Scale</measure>
    <time_frame>day 1</time_frame>
    <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at the Stapler Port Site as Assessed by a Visual Analog Scale</measure>
    <time_frame>1 week</time_frame>
    <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at the Stapler Port Site as Assessed by a Visual Analog Scale</measure>
    <time_frame>6 weeks</time_frame>
    <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as Assessed by Number of Participants Who Took Pain Medications</measure>
    <time_frame>week 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain as Assessed by Number of Participants Who Took Pain Medications</measure>
    <time_frame>week 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Stay Duration</measure>
    <time_frame>from the the time of hospital admission to the time of hospital discharge (about 1.29 to 2.95 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Surgical Port Site Hernia</condition>
  <arm_group>
    <arm_group_label>Neo Close Abdominal Closure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Carter Thomason Device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neo Close Abdominal Closure</intervention_name>
    <description>Neo Close Abdominal Closure</description>
    <arm_group_label>Neo Close Abdominal Closure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Carter Thomason Device</intervention_name>
    <description>Carter Thomason Device</description>
    <arm_group_label>Carter Thomason Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Morbid obesity (BMI &gt; 35).

          -  Completed multimodality pre operative evaluation (Psychology, Nutrition, Support
             Groups).

          -  Approved for robotic assisted laparoscopic gastric bypass.

        Exclusion Criteria:

          -  Previous midline laparotomy or weight loss procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shinil Shah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>October 20, 2015</study_first_submitted>
  <study_first_submitted_qc>October 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2015</study_first_posted>
  <results_first_submitted>July 26, 2019</results_first_submitted>
  <results_first_submitted_qc>July 26, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 15, 2019</results_first_posted>
  <last_update_submitted>August 17, 2019</last_update_submitted>
  <last_update_submitted_qc>August 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Shinil Shah</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 2, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/71/NCT02589171/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Neo Close Abdominal Closure</title>
          <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
        </group>
        <group group_id="P2">
          <title>Carter Thomason Device</title>
          <description>Carter Thomason Device: Carter Thomason Device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Day 1 Follow up</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 1 Follow up</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 6 Follow up</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Neo Close Abdominal Closure</title>
          <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
        </group>
        <group group_id="B2">
          <title>Carter Thomason Device</title>
          <description>Carter Thomason Device: Carter Thomason Device</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="35"/>
            <count group_id="B3" value="70"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" spread="12"/>
                    <measurement group_id="B2" value="45" spread="11"/>
                    <measurement group_id="B3" value="46" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Technical Effectiveness as Assessed by Number of Sutures Required to Complete Closure at the Camera Port Site</title>
        <time_frame>at the time of surgery</time_frame>
        <population>Data were not available for 4 in the NeoClose arm and 3 in the Carter Thomason arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Technical Effectiveness as Assessed by Number of Sutures Required to Complete Closure at the Camera Port Site</title>
          <population>Data were not available for 4 in the NeoClose arm and 3 in the Carter Thomason arm.</population>
          <units>number of sutures</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="0"/>
                    <measurement group_id="O2" value="1.84" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Technical Effectiveness as Assessed by Number of Sutures Required to Complete Closure at the Stapler Port Site</title>
        <time_frame>at the time of surgery</time_frame>
        <population>Data were not available for 5 in the NeoClose arm and 6 in the Carter Thomason arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Technical Effectiveness as Assessed by Number of Sutures Required to Complete Closure at the Stapler Port Site</title>
          <population>Data were not available for 5 in the NeoClose arm and 6 in the Carter Thomason arm.</population>
          <units>number of sutures</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="0"/>
                    <measurement group_id="O2" value="1.83" spread="0.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Technical Effectiveness as Assessed by the Time Required to Complete Closure at the Camera Port Site</title>
        <time_frame>at the time of surgery</time_frame>
        <population>Data were not available for 1 in the Carter Thomason arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Technical Effectiveness as Assessed by the Time Required to Complete Closure at the Camera Port Site</title>
          <population>Data were not available for 1 in the Carter Thomason arm.</population>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.95" spread="11.73"/>
                    <measurement group_id="O2" value="33.23" spread="25.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Technical Effectiveness as Assessed by the Time Required to Complete Closure at the Stapler Port Site</title>
        <time_frame>at the time of surgery</time_frame>
        <population>Data were not available for 3 in the Carter Thomason arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Technical Effectiveness as Assessed by the Time Required to Complete Closure at the Stapler Port Site</title>
          <population>Data were not available for 3 in the Carter Thomason arm.</population>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.49" spread="7.79"/>
                    <measurement group_id="O2" value="28.63" spread="11.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Technical Effectiveness as Assessed by Depth of Needle Penetration to Complete Closure at Both the Camera Port Site and Stapler Port Site</title>
        <time_frame>at the time of surgery</time_frame>
        <population>Data were not available for 12 participants in the NeoClose arm and 16 participants in the Carter Thomason arm. For each participant analyzed, there were needle depth data available for 1, 2, 3, or 4 stitches per participant.</population>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Technical Effectiveness as Assessed by Depth of Needle Penetration to Complete Closure at Both the Camera Port Site and Stapler Port Site</title>
          <population>Data were not available for 12 participants in the NeoClose arm and 16 participants in the Carter Thomason arm. For each participant analyzed, there were needle depth data available for 1, 2, 3, or 4 stitches per participant.</population>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>stitch</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>stitch</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="0.93"/>
                    <measurement group_id="O2" value="4.9" spread="1.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Technical Effectiveness as Assessed by Number of Participants With Surgical Site Occurrences Post-Operatively</title>
        <description>Surgical site occurrences include hematoma, seroma, or infection and were assessed by physical exam.</description>
        <time_frame>immediately post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Technical Effectiveness as Assessed by Number of Participants With Surgical Site Occurrences Post-Operatively</title>
          <description>Surgical site occurrences include hematoma, seroma, or infection and were assessed by physical exam.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Technical Effectiveness as Assessed by Number of Participants With Surgical Site Occurrences Post-Operatively</title>
        <description>Surgical site occurrences include hematoma, seroma, or infection and were assessed by physical exam.</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Technical Effectiveness as Assessed by Number of Participants With Surgical Site Occurrences Post-Operatively</title>
          <description>Surgical site occurrences include hematoma, seroma, or infection and were assessed by physical exam.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Technical Effectiveness as Assessed by Number of Participants With Surgical Site Occurrences Post-Operatively</title>
        <description>Surgical site occurrences include hematoma, seroma, or infection and were assessed by physical exam.</description>
        <time_frame>6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Technical Effectiveness as Assessed by Number of Participants With Surgical Site Occurrences Post-Operatively</title>
          <description>Surgical site occurrences include hematoma, seroma, or infection and were assessed by physical exam.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Technical Effectiveness as Assessed by Number of Participants With Presence of Port Site Hernia Post-operatively</title>
        <description>Abdominal ultrasound will be used to detect port site hernia.</description>
        <time_frame>6 weeks</time_frame>
        <population>Data were not available for 1 in the Carter Thomason arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Technical Effectiveness as Assessed by Number of Participants With Presence of Port Site Hernia Post-operatively</title>
          <description>Abdominal ultrasound will be used to detect port site hernia.</description>
          <population>Data were not available for 1 in the Carter Thomason arm.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at the 12mm Camera Port Site as Assessed by a Visual Analog Scale</title>
        <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
        <time_frame>day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at the 12mm Camera Port Site as Assessed by a Visual Analog Scale</title>
          <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.66" spread="1.21"/>
                    <measurement group_id="O2" value="0.66" spread="1.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at the 12mm Camera Port Site as Assessed by a Visual Analog Scale</title>
        <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at the 12mm Camera Port Site as Assessed by a Visual Analog Scale</title>
          <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="0.84"/>
                    <measurement group_id="O2" value="0.74" spread="1.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at the 12mm Camera Port Site as Assessed by a Visual Analog Scale</title>
        <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
        <time_frame>6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at the 12mm Camera Port Site as Assessed by a Visual Analog Scale</title>
          <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0.07" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at the Stapler Port Site as Assessed by a Visual Analog Scale</title>
        <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
        <time_frame>day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at the Stapler Port Site as Assessed by a Visual Analog Scale</title>
          <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="1.89"/>
                    <measurement group_id="O2" value="1.00" spread="2.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at the Stapler Port Site as Assessed by a Visual Analog Scale</title>
        <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at the Stapler Port Site as Assessed by a Visual Analog Scale</title>
          <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" spread="1.50"/>
                    <measurement group_id="O2" value="1.03" spread="1.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at the Stapler Port Site as Assessed by a Visual Analog Scale</title>
        <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
        <time_frame>6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at the Stapler Port Site as Assessed by a Visual Analog Scale</title>
          <description>Pain Score is based on a visual analog scale (VAS), with a range of 0 to 10. 0 indicates no pain and 10 indicates the most painful.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain as Assessed by Number of Participants Who Took Pain Medications</title>
        <time_frame>week 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Pain as Assessed by Number of Participants Who Took Pain Medications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain as Assessed by Number of Participants Who Took Pain Medications</title>
        <time_frame>week 6</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Pain as Assessed by Number of Participants Who Took Pain Medications</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Stay Duration</title>
        <time_frame>from the the time of hospital admission to the time of hospital discharge (about 1.29 to 2.95 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Neo Close Abdominal Closure</title>
            <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
          </group>
          <group group_id="O2">
            <title>Carter Thomason Device</title>
            <description>Carter Thomason Device: Carter Thomason Device</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Stay Duration</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.12" spread="0.57"/>
                    <measurement group_id="O2" value="2.12" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Neo Close Abdominal Closure</title>
          <description>Neo Close Abdominal Closure: Neo Close Abdominal Closure</description>
        </group>
        <group group_id="E2">
          <title>Carter Thomason Device</title>
          <description>Carter Thomason Device: Carter Thomason Device</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="35"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Associate Professor</name_or_title>
      <organization>The University of Texas Health Science Center at Houston</organization>
      <phone>(713) 500-7277</phone>
      <email>Shinil.K.Shah@uth.tmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

